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Abstract
A 900-MHz NMR study is reported of peptide sMTM7 that mimics the cytoplasmic proton hemi-channel domain of the seventh
transmembrane segment (TM7) from subunit a of H+-V-ATPase from Saccharomyces cerevisiae. The peptide encompasses the amino acid
residues known to actively participate in proton translocation. In addition, peptide sMTM7 contains the amino acid residues that upon mutation
cause V-ATPase to become resistant against the inhibitor bafilomycin. 2D TOCSY and NOESY 1H–1H NMR spectra are obtained of sMTM7
dissolved in d6-DMSO and are used to calculate the three-dimensional structure of the peptide. The NMR-based structures and corresponding
dynamical features of peptide sMTM7 show that sMTM7 is composed of two α-helical regions. These regions are separated by a flexible hinge of
two residues. The hinge acts as a ball-and-joint socket and both helical segments move independently with respect to one another. This movement
in TM7 is suggested to cause the opening and closing of the cytoplasmic proton hemi-channel and enables proton translocation.
© 2007 Elsevier B.V. All rights reserved.Keywords: NMR; Transmembrane; V-ATPase subunit a; Peptide conformation; Proton translocation1. Introduction
One of the most important balances required for cell
maintenance and activity is the establishment of differences in
pH between various cellular organelles. This balance is mainlyAbbreviations: CSI, Chemical shift index; DMSO, Dimethylsulfoxide; DSS,
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doi:10.1016/j.bbamem.2007.05.014provided by vacuolar proton ATPases (V-ATPases)1, which act
as molecular motors that pump protons across a membrane.
Proton translocation occurs at the expense of ATP that is
hydrolyzed in the V1 catalytic cytoplasmic domain of V-
ATPase. The protons involved pass the membrane through the
transmembrane VO domain. This domain contains subunits a,
d, e, which are part of the stator of the molecular motor, and
proteolipid subunits c, c′ and c″ (c-subunits) that make up the
rotor [1].
V-ATPases reside in membranes of vacuoles, endosomes and
lysosomes and cause the acidification of theses compartments
[2,3]. In specific cases V-ATPase is present in the cell
membrane causing the acidification of the extracellular space.
Such extracellular acidification happens in the case of
osteoclasts, which are a particular type of bone cells. In
osteoclasts deregulation of H+-V-ATPase can lead to bone
demineralization leading to osteoporosis. Although several
drugs are available to reduce bone loss they only have a
temporary effect. One factor that impedes the discovery of new
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information about the VO domain of V-ATPase. The structure of
the rotor subunits has recently been elucidated for a related
enzyme, the Na+-V-ATPase [4]. However, no high-resolution
structure is available for the stator subunits. Recently, our group
experimentally demonstrated [5,6] that the seventh transmem-
brane segment (TM7) of the stator subunit a of V-ATPase
possesses α-helical properties. However, no structure at atomic
resolution could be obtained. Interest in the three-dimensional
structure and chemical and physical properties of TM7 is high
as several of its residues were shown to be involved in the
binding of inhibitors of V-ATPase [7].
Subunit a of V-ATPase is composed of nine putative
transmembrane sections and a 400-residue cytoplasmic section
[8,9]. Residue R735 of TM7 plays a vital role since its mutation
provokes total inhibition of proton translocation [8]. Mutating
histidine residues H729 and H743 of TM7 also affects proton
translocation, although their effect is less pronounced compared
to the mutations of R735.
Proteolipid rotor subunits c, c′ and c″ are transmembrane
subunits also involved in proton translocation. They are
composed of four TM segments and c″ has an additional fifth
cytoplasmic segment. The glutamic acid residues of the fourth
putative TM segment of c and c′, and of the second putative
transmembrane segment of c″ are of fundamental importance
for proton translocation [2,9,10]. Two hemi-channels provide a
proposed pathway that protons can follow during their
translocation [11]. It is assumed that rotation of the rotor,
which is due to hydrolysis of ATP in the V1 domain, forces
protonation of the glutamic acid residues mentioned. Protons
can access the carboxylic side chain of these residues via a
cytoplasmic hemi-channel that is located in the interface
between subunit a and the rotor. When a c-subunit rotates the
release of another proton into the luminal hemi-channel occurs.
This release is assisted by R735 of TM7 as it stabilizes the
negatively charged side chain of the glutamic acid involved.
The cytoplasmic hemi-channel acts as a binding pocket for
bafilomycin [7] and the potential residues involved are lo-
cated at the interface between TM4 (of the rotor) and TM7
(of subunit a). During proton translocation the relative
orientation of these two helical segments changes due to
rotation of one or of both helical segments [12]. Inhibition of
proton translocation occurs when these two segments are
constrained to one rigid conformation that prohibits theFig. 1. Amino acid alignment of the TM7 segment of V-ATPase subunit a of yeast wit
human and Chinese hamster, respectively. Activity related-amino acid residues of T
sMTM7 is indicated by a horizontal box. Amino acid residues that upon substitution
circles [7]. Arrows show the amino acid residues that strongly cross link with the
sequence of full-length subunit a.swiveling of the glutamic acid located in the centre of the
rotor [13].
Here, a 900-MHz NMR study is reported of peptide sMTM7
(Fig. 1) that mimics the cytoplasmic proton hemi-channel
domain of TM7 from the yeast Saccharomyces cerevisiae.
Peptide sMTM7 is a shorter version of peptide MTM7 that we
studied previously [5], but still encompasses the amino acid
residues known to actively participate in the cytoplasmic proton
translocation hemi-channel (i.e., H729, R735, H743). In
addition, peptide sMTM7 contains the amino acid residues
that upon substitution cause V-ATPase to become resistant
against bafilomycin (i.e., residues E721, L724 and N725) [7].
The use of a shortened version of MTM7 leads to 2D 1H–1H
NMR spectra of sufficient quality to extract NOE constrains and
calculate the three-dimensional structure of the peptide at
atomic resolution. The NMR-based structures of peptide
sMTM7 provide new insight in the involvement of TM7 of
subunit a in proton translocation.
2. Materials and methods
2.1. Peptide design and synthesis
The 25-residue peptide sMTM7 was designed (Fig. 1) based on the putative
localization of MTM7 in the cytoplasmic hemi-channel [5,7,9]. Throughout this
paper the sequential numbering of amino acid residues of peptide sMTM7 is
identical to the one used for subunit a in V-ATPase (Fig. 1). Peptide sMTM7
was produced on solid support using continuous flow chemistry by Pepceuticals
Ltd., Leicester, UK. Its purity was tested by mass spectrometry and found to be
larger than 90%.
2.2. NMR measurements
Peptide sMTM7 is a highly hydrophobic peptide with a low solubility in
aqueous systems. Different membrane-mimicking solvents were tested,
however, only the use of DMSO avoided aggregation at peptide concentrations
needed for NMR spectroscopy (data not shown). Consequently, DMSO was
used to obtain 2D 1H–1H NMR and natural abundance 2D 1H–13C spectra of
peptide sMTM7 with sufficient signal-to-noise ratio.
NMR samples were made by dissolving peptide sMTM7 in 500 μL d6-
DMSO (Cambridge Isotopes) to a concentration of 2 mM. DSS (Cambridge
Isotopes) was used as internal standard. 1H and natural abundance 13C NMR
spectra were recorded at 900 MHz on a Bruker DRX900 spectrometer. 2D
1H–1H-NOESY, 1H–1H-TOCSY, and natural abundance 2D 1H–13C HSQC and
HMBC spectra were recorded according to Ref. [14]. All spectra were recorded
at 30 °C. 2D NOESYexperiments were acquired with mixing times of 100, 200,
and 300 ms. 2D TOCSY experiments were acquired with a mixing time of
70 ms. In case of all 2D-NMR experiments 2K data points were collected in theh the equivalent TM segment of subunit a from F-ATPase (i.e., TM4) from yeast,
M7 from yeast V-ATPase are shown in red (H729, R735 and H743). Peptide
cause V- and F-ATPase to become resistant against bafilomycin are shown by
proteolipid subunits c′ and c″ [12,13]. Amino acid numbering is based on the
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width was 11 ppm for 1H and 140 ppm for 13C for both 2D 1H–13C HMBC and
HSQC. NMR data were processed using XWINNMR from Bruker. Peak
assignment and spectral analysis were carried out using the software Sparky
(Goddard, T. D., and Kneller, D. G., University of California, San Francisco)
running under Linux.
2.3. Structure calculations
The software package CNS[15] combined with the ARIA 1.2 setup and
protocols[16,17] was used to calculate structures of peptide sMTM7 that are
consistent with the obtained NMR data. As input for the structure determination
and refinement ambiguously and unambiguously identified NOE contacts were
used. A simulated annealing protocol in Cartesian space was employed. The
protocol starts with an extended conformation of peptide sMTM7 and involves
four stages: (a) simulated annealing stage at 2000 K (10000 steps); (b) first
cooling phase to 1000 K in 5000 steps; (c) second cooling stage to 50 K in 2000
steps; (d) final 200 steps of energy minimization. The time step for integration
was set to 0.003 ps. The resulting structures were subjected to a final refinement
by solvation with DMSO. A total of 160 structures were calculated and out of
these 20 structures that have the lowest energies were selected. The RMSD
calculations and superimposition were performed with the software package
MOLMOL [18].3. Results
3.1. Assignment of NMR resonances of sMTM7 in d6-DMSO
2D 1H–1H TOCSY, 1H–1H NOESY and natural abundance
1H–13C HSQC and HMBC spectra are recorded of peptide
sMTM7 in d6-DMSO. Assignment of its spin systems is based
on the technique of sequential resonance assignments[19,20] by
making interactive interpretations of the 2D 1H–1H TOCSYand
2D 1H–1H NOESY spectra. Fig. 2 shows the 1HN–
1Hα and
1HN–
1HN regions of the 300-ms NOESY spectrum of sMTM7.
The resonance assignments are provided in Table 1 of the
Supplemental Data and are deposited, together with the NOESY
assignments, in the BioMagResbank under access number
15025.
The 13C spectra provide information that facilitates the
assignment procedure. In addition, the chemical shifts of 13Cβ
of C723 (38.254 ppm) and of C726 (36.953 ppm) report aboutFig. 2. Fingerprint 1HN–
1HN (A) and
1HN–
1Hα (B) regions of the 900-MHz 2D-NOEthe oxidative state of the cysteine residues. As the 13Cβ
chemical shift of reduced cysteines fall in the region 24–33 ppm
and those of oxidized cysteines in the region 34–52 ppm
[21,22] it is concluded that C723 and C728 are involved in a
disulphide bond. No inter-molecular cross-links between
sMTM7 molecules are identified in the 2D-NOESY spectra.
Consequently, C723 and C726 are linked by an intramolecular
disulphide bond and sMTM7 is monomeric.
3.2. Secondary structure
The chemical shift index (CSI)[23] is calculated for the 1Hα
protons of sMTM7 (Fig. 3). Many residues have a propensity to
be in an α-helix configuration as is inferred from consecutive
negative 1Hα CSI values, with residues V727, L734 and L736
being exceptions.
The observation of specific sequential and medium-range
NOE contacts can be used to infer the secondary structure of
peptides and proteins [19,20]. The NOE connectivities relevant
to do the latter for peptide sMTM7 (i.e., dαN(i, i+3), dαN(i, i+4)
and dαN(i, i+5) connectivities) are shown in Fig. 3. A helical
region exists between C723 and A738 as suggested by many
NOEs (seven dαN(i,i+3), eight dαN(i,i+4) and three dαN(i,i+5)
connectivities) and its presence is supported by the CSI data.
The absence of dαN(i,i+4) and dαN(i,i+5) NOE contacts in the
region T730–A731 suggests that the helical segment might be
disrupted. In the region A738–Q745 only one dαN(i,i+4) NOE
contact is found, which suggests that this part of the peptide does
not adopt a helical conformation.
3.3. Structure calculations
A number of 545 distance constraints extracted from the
1H–1H-NOESY spectrum of peptide sMTM7 are used as
input for the structure calculation procedure. These con-
straints include the NOE contacts shown in Fig. 3, as well
as medium- and long-range NOE contacts identified between
side chains of different amino acid residues. The confor-
mational properties of the resulting 20 lowest energy struc-SY spectrum of peptide sMTM7 in d6-DMSO at 30 °C (mixing time of 300 ms).
Fig. 3. Summary of several secondary structure data obtained for peptide sMTM7 in d6-DMSO at 30 °C. (A) Chemical Shift Index for
1Hα (■), residues
with CSI values that lie below −0.1 (- - - -) have a high probability to be in an α-helical conformation. (B) NOE connectivities dαN(i, i+3), dαN(i, i+4) and
dαN(i, i+5). C: Secondary structure within peptide sMTM7 as deduced from NOEs and from the simulated annealing approach that leads to structures at
atomic resolution.
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These structures are deposited in the PDB databank with
reference 2NVJ. Fig. 5 depicts the ribbon drawings of these
structures. Fig. 4 shows that several regions of peptide sMTM7
are able to adopt different secondary structures. For example
region S732–R735 adopts an α-helical conformation in ten
structures, a 310-helix in three structures and turn/bend con-
formations in seven of the 20 lowest energy structures
calculated.
Taking into account the conformations obtained from the
structure calculations (Fig. 4), two main regions in peptide
sMTM7 that populate helical conformations are identified:
C723–H729 and S732–A738. RMSD minimization fits of
three different regions of the backbone of the 20 lowest
energy structures calculated are shown in Fig. 6. The super-
imposition of the structures confined to either of the two
identified helical regions (C723–H729 and S732–A738) leads
to relatively low RMSD values thereby confirming the helical
character of both sections of sMTM7. These two helical
regions act as separate moieties that move independently with
respect to one another due to the less rigid section involvingT730–A731 (Fig. 6A and B). The existence of such a flexible
region is confirmed by the identification of weak long-
distance NOE contacts between the side chains of residues
located in Helix 1 and Helix 2 (for example, a NOE contact is
found between the sidechains of E721 and Q745). These
NOE contacts are included in the structure determination
procedure (all NOE contacts have been deposited in the Bio-
MagResbank). A RMSD minimization of the region T730–
A731 (Fig. 6C) shows that both helical regions move
independently with respect to one another. The region L-739–
Q745 of sMTM7 is fraying.
4. Discussion
To study the intrinsic conformational properties of the
putative cytoplasmic hemi-channel region of TM7 of V-ATPase
subunit a a 25-residue peptide sMTM7 was designed as a
mimic of TM7. The putative TM7 has α-helical character in
different membrane-mimicking solvents (SDS, DMSO, TFE
and lipid bilayers) [5,6,24]. However, no three-dimensional
structure at atomic resolution is available for TM7. Here the
Fig. 4. Matrix representation of the conformational properties of the 20 lowest energy structures of peptide sMTM7 as determined by the ARIA software. The
horizontal axis represents the sequence of peptide sMTM7 and the vertical axis shows the corresponding secondary structure element in each of the structures
calculated.
Fig. 5. Ribbon representations of the conformations of the 20 lowest energy
structures determined of peptide sMTM7 in d6-DMSO. Structures are drawn
with the software package MOLMOL [18]. These structures are deposited in the
PDB databank with reference 2NVJ.
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result new insight in the involvement of TM7 in proton
translocation is obtained.
Recently, ESR spectroscopy and Molecular Dynamics
simulations suggested that peptide sMTM7 adopts α-helical
conformation in SDS micelles [6]. The 2D 1H–1H-NMR
studies reported here require much higher concentrations of
peptide sMTM7 as compared to what is needed in the ESR
studies [6]. DMSO is commonly used as an appropriate
solvent to study the structure and dynamics of various
membrane peptides [5,25–28]. DMSO indeed allows the use
of the high sMTM7 concentrations (i.e., 2 mM) needed to
obtain high-resolution 2D 1H–1H NMR spectra of sufficient
quality. Other solvents have been tested as well, but the
solubility of peptide sMTM7 is either too low or the obtained
signal-to-noise ratio is too poor. The three-dimensional
structure and dynamics of peptide sMTM7 in DMSO are
determined by using NMR spectroscopy at 900 MHz to
obtain good sensitivity and dispersion of the resonances
involved. All spin systems (i.e., amino acid residues) are
assigned in the TOCSY spectrum and 80% of the NOEs
observed could be unambiguously assigned in the NOESY
spectra.
The combination of CSI values and NOE contacts (Fig. 3)
indicates that peptide sMTM7 predominantly adopts an α-
helical structure in the region between C723 and A738. The
identification of three dαN(i,i+5) contacts (L724–H729, N725–
T730 and S732–W737) suggest that in these regions of the
peptide a conformational exchange between α-helical and more
loosened helical conformation occurs (π-helical).
The 20 lowest energy structures derived for peptide
sMTM7 (Figs. 4 and 5) show that the peptide is composed
Fig. 6. Three RMSD-minimized superposition of the Cα traces of the 20 lowest energy structures calculated for peptide sMTM7 using the software MOLMOL [18].
The RMSD is minimized for the following three regions of the peptide: (A) residues C723–H729 (RMSD: 1.130 Å), (B) residues S732–A738 (RMSD: 3.212 Å), and
(C) residues T730–A731 (RMSD: 0.890 Å). The regions with RMSD-minimization are depicted in the ribbon representation, the remaining sections are depicted in
their Cα traces. The four regions identified in sMTM7 are differently colored for the purpose of distinction: blue—E721–H729, black—T730–A731, red—S732–
A738 and dark grey—A738–Q745.
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These two helical segments are separated by a region (T730–
A731) in which coil/bend/turn conformations are predomi-nantly populated (see Fig. 4). In the C-terminal part of
peptide sMTM7 no medium nor long-range NOEs are de-
tected between residues A738 and Q745 and as a conse-
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mainly populates coil/bend/turn conformations, which reflects
conformational fraying. C-termini of peptides have stronger
fraying properties than N-termini [29,30]. In case of sMTM7
the disulphide bridge that links C723 and C726 contributes
to the virtual absence of fraying of the N-terminus (Fig. 6A).
The first helical segment of sMTM7 is apparently dynamic
as it can adopt turn, bend and π-helical conformations and
resembles a loosened α-helix (Figs. 4–6). The second helical
segment of sMTM7 adopts α-helical and 310-helical
conformations. This part of sMTM7 is less dynamic com-
pared to the first helical section as turn and bend structures
are hardly populated. Both helical segments are connected by
two amino acid residues (T730 and A731) that adopt turn
and bend conformations (Fig. 4). As a result, both helical
segments move independently with respect to one another
(Fig. 6).
Previous NMR studies in which a 12-residue longer version
of peptide sMTM7 was used [5] postulate that the C723–A731
region is helical. However, on the basis of the previous data
which lack assignments due to the size of the molecule
investigated and in which NOEs are only qualitatively
interpreted, it could not be excluded that this helical segments
contains small non-helical segments. The refined study
presented here indeed shows that TM7 does not adopt a
continuous α-helical structure, but instead it has a flexible non-
helical hinge region at T730–A731. A recent study from
Underhaug [31] identified a flexible region in a peptide from the
Na+,K+-ATPase that was correlated with a flexible region in the
native protein. Backbone hinges that interrupt transmembrane
helical segments have been identified for other transmembrane
protein [32].
The conformational characteristics observed for peptide
sMTM7 reflect the intrinsic proprieties of the peptide.
Consequently, it is proposed that the sMTM7 part of TM7
exhibits similar behavior when it is located in its natural
environment, subunit a of V-ATPase. How might the flexible
hinge at T730–A731 affect the proton translocation properties
of the sMTM7 region of the VO domain? The second helical
region of peptide sMTM7, which contains arginine 735,
needs to be positioned in the centre of the membrane bilayer,
thereby facing the central glutamic acids of the rotor (located
at TM2 and TM4). As a consequence, the first helical region
of sMTM7 is located in the cytoplasmic proton hemi-channel,
in agreement with the bafilomycin binding data [7] (see Fig.
7). The flexible region of TM7 (i.e., T730–A731) that
connects two helical segments thus is located near the end of
the cytoplasmic hemi-channel (i.e. almost in the centre of the
bilayer) (see Fig. 7). As region A738–Q745 does not fray inFig. 7. Proposed model for opening and closing of the cytoplasmic hemi-channel of V
entry: 2BL2). From subunit a only the section of TM7 that includes peptide sMTM7 is
[4]. Peptide sMTM7 is depicted as an α-helix with the exception of residues T730 and
that can allow Helix 1 and Helix 2 to move independently with respect to one anoth
(depicted as a stick model) are colored red, while the other hydrophilic residues are co
TM7, based on the work presented here, that allow the cytoplasmic hemi-channel to
with the software package Chimera [33].the extended version MTM7 of sMTM7 and as it has been
shown to be helical in TM7 [5], this region is depicted as an
helix in Fig. 7. We speculate that this proposed arrangement
of the peptide in the hemi-channel could allow movement of
protons to the centre of the rotor via rotation and adjustment
of the first helical segment, thereby opening and closing the
passage for protons to the centre of the membrane res-
pectively (see blue arrows in Fig. 7). This movement could
allow the correct orientation of the helical faces expected to
be face-to-face during the different steps of proton transloca-
tion. Previously, Kawasaki-Nishi et al. [12] proposed that
TM7 is a rigid helix and that changes in the orientation of
TM4/TM2 relative to TM7 explain the experimental cross-
links identified between TM7 and TM4/TM2. However,
when TM7 consists of two helical segments that can rotate
independently from one another, as we suggest, also explains
the experimental cross-links observed between TM7 and
TM4/TM2. Residues T730 and A731 can act as a dynamical
ball-and-socket joint, which links two helical segments of
sMTM7 in TM7. We propose that the autonomous movement
of the N-terminal helical segment, which is positioned in the
cytoplasmic hemi-channel, causes the proton translocation
channel to open and close thereby enabling proton transloca-
tion (see blue arrows in Fig. 7).
The autonomous movement of the first helical segment of
TM7 could also be relevant for the binding of inhibitors to
specific amino acid residues of F- and V-ATPases (Fig. 1).
Since the cytoplasmic loop that connects TM7 to TM6 is
quite long (approximately 65 residues) dynamic movement
of helix 1 of TM7 could be compensated by a movement
further up in this loop. The existence of such a movement
opens new opportunities for drug design. Inhibitors that bind
to the cytoplasmic loop segment could rigidify it and thereby
potentially disable the translocation of protons.
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